| UniProt ID | CXXC1_HUMAN | |
|---|---|---|
| UniProt AC | Q9P0U4 | |
| Protein Name | CXXC-type zinc finger protein 1 | |
| Gene Name | CXXC1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 656 | |
| Subcellular Localization | Nucleus speckle . Associated with euchromatin. During mitosis, excluded from condensed chromosomes. | |
| Protein Description | Transcriptional activator that exhibits a unique DNA binding specificity for CpG unmethylated motifs with a preference for CpGG.. | |
| Protein Sequence | MEGDGSDPEPPDAGEDSKSENGENAPIYCICRKPDINCFMIGCDNCNEWFHGDCIRITEKMAKAIREWYCRECREKDPKLEIRYRHKKSRERDGNERDSSEPRDEGGGRKRPVPDPDLQRRAGSGTGVGAMLARGSASPHKSSPQPLVATPSQHHQQQQQQIKRSARMCGECEACRRTEDCGHCDFCRDMKKFGGPNKIRQKCRLRQCQLRARESYKYFPSSLSPVTPSESLPRPRRPLPTQQQPQPSQKLGRIREDEGAVASSTVKEPPEATATPEPLSDEDLPLDPDLYQDFCAGAFDDHGLPWMSDTEESPFLDPALRKRAVKVKHVKRREKKSEKKKEERYKRHRQKQKHKDKWKHPERADAKDPASLPQCLGPGCVRPAQPSSKYCSDDCGMKLAANRIYEILPQRIQQWQQSPCIAEEHGKKLLERIRREQQSARTRLQEMERRFHELEAIILRAKQQAVREDEESNEGDSDDTDLQIFCVSCGHPINPRVALRHMERCYAKYESQTSFGSMYPTRIEGATRLFCDVYNPQSKTYCKRLQVLCPEHSRDPKVPADEVCGCPLVRDVFELTGDFCRLPKRQCNRHYCWEKLRRAEVDLERVRVWYKLDELFEQERNVRTAMTNRAGLLALMLHQTIQHDPLTTDLRSSADR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MEGDGSDP -------CCCCCCCC | 13.50 | 21406692 | |
| 6 | Phosphorylation | --MEGDGSDPEPPDA --CCCCCCCCCCCCC | 55.52 | 28355574 | |
| 17 | Phosphorylation | PPDAGEDSKSENGEN CCCCCCCCCCCCCCC | 33.50 | 26074081 | |
| 19 | Phosphorylation | DAGEDSKSENGENAP CCCCCCCCCCCCCCC | 40.00 | 20164059 | |
| 28 | Phosphorylation | NGENAPIYCICRKPD CCCCCCEEEEECCCC | 3.76 | 26074081 | |
| 63 | Acetylation | RITEKMAKAIREWYC HHHHHHHHHHHHHHH | 40.63 | 19608861 | |
| 110 | Ubiquitination | RDEGGGRKRPVPDPD CCCCCCCCCCCCCHH | 65.41 | 29967540 | |
| 124 | Phosphorylation | DLQRRAGSGTGVGAM HHHHHCCCCCCHHHH | 32.00 | 21815630 | |
| 125 | Ubiquitination | LQRRAGSGTGVGAML HHHHCCCCCCHHHHH | 26.10 | 24816145 | |
| 126 | Phosphorylation | QRRAGSGTGVGAMLA HHHCCCCCCHHHHHH | 30.32 | 21406692 | |
| 131 | Sulfoxidation | SGTGVGAMLARGSAS CCCCHHHHHHCCCCC | 2.18 | 21406390 | |
| 136 | Phosphorylation | GAMLARGSASPHKSS HHHHHCCCCCCCCCC | 21.74 | 28152594 | |
| 138 | Phosphorylation | MLARGSASPHKSSPQ HHHCCCCCCCCCCCC | 29.27 | 23927012 | |
| 142 | Phosphorylation | GSASPHKSSPQPLVA CCCCCCCCCCCCCCC | 44.19 | 23927012 | |
| 143 | Phosphorylation | SASPHKSSPQPLVAT CCCCCCCCCCCCCCC | 32.15 | 23927012 | |
| 150 | Phosphorylation | SPQPLVATPSQHHQQ CCCCCCCCCCHHHHH | 18.92 | 23927012 | |
| 152 | Phosphorylation | QPLVATPSQHHQQQQ CCCCCCCCHHHHHHH | 37.48 | 23401153 | |
| 163 | Methylation | QQQQQQIKRSARMCG HHHHHHHHHHHHHHH | 35.64 | - | |
| 163 | Ubiquitination | QQQQQQIKRSARMCG HHHHHHHHHHHHHHH | 35.64 | 29967540 | |
| 198 | Acetylation | KKFGGPNKIRQKCRL HHHCCCHHHHHHHHH | 42.26 | 25953088 | |
| 215 | Phosphorylation | CQLRARESYKYFPSS HHHHHHHHHHCCCCC | 22.75 | 23312004 | |
| 216 | Phosphorylation | QLRARESYKYFPSSL HHHHHHHHHCCCCCC | 12.64 | 23312004 | |
| 218 | Phosphorylation | RARESYKYFPSSLSP HHHHHHHCCCCCCCC | 16.70 | 21712546 | |
| 221 | Phosphorylation | ESYKYFPSSLSPVTP HHHHCCCCCCCCCCC | 33.73 | 23401153 | |
| 222 | Phosphorylation | SYKYFPSSLSPVTPS HHHCCCCCCCCCCCC | 32.86 | 30266825 | |
| 224 | Phosphorylation | KYFPSSLSPVTPSES HCCCCCCCCCCCCCC | 21.19 | 30266825 | |
| 227 | Phosphorylation | PSSLSPVTPSESLPR CCCCCCCCCCCCCCC | 25.20 | 25159151 | |
| 229 | Phosphorylation | SLSPVTPSESLPRPR CCCCCCCCCCCCCCC | 30.37 | 21712546 | |
| 231 | Phosphorylation | SPVTPSESLPRPRRP CCCCCCCCCCCCCCC | 48.27 | 21712546 | |
| 248 | Phosphorylation | TQQQPQPSQKLGRIR CCCCCCCCHHHCCCC | 34.40 | 28555341 | |
| 250 | Sumoylation | QQPQPSQKLGRIRED CCCCCCHHHCCCCCC | 58.19 | - | |
| 250 | Sumoylation | QQPQPSQKLGRIRED CCCCCCHHHCCCCCC | 58.19 | 28112733 | |
| 250 | Ubiquitination | QQPQPSQKLGRIRED CCCCCCHHHCCCCCC | 58.19 | 24816145 | |
| 250 | Acetylation | QQPQPSQKLGRIRED CCCCCCHHHCCCCCC | 58.19 | 23954790 | |
| 263 | Phosphorylation | EDEGAVASSTVKEPP CCCCCCCCCCCCCCC | 21.68 | 29514088 | |
| 264 | Phosphorylation | DEGAVASSTVKEPPE CCCCCCCCCCCCCCC | 27.73 | 30108239 | |
| 265 | Phosphorylation | EGAVASSTVKEPPEA CCCCCCCCCCCCCCC | 32.85 | 30108239 | |
| 308 | Phosphorylation | DHGLPWMSDTEESPF CCCCCCCCCCCCCCC | 37.20 | 26074081 | |
| 310 | Phosphorylation | GLPWMSDTEESPFLD CCCCCCCCCCCCCCC | 34.05 | 26074081 | |
| 328 | Methylation | RKRAVKVKHVKRREK HHHHHHHHHHHHHHH | 36.64 | - | |
| 359 | Ubiquitination | QKHKDKWKHPERADA HHHHHHCCCHHHCCC | 55.83 | 29967540 | |
| 363 | Ubiquitination | DKWKHPERADAKDPA HHCCCHHHCCCCCCC | 42.07 | 29967540 | |
| 367 | Acetylation | HPERADAKDPASLPQ CHHHCCCCCCCCCCC | 65.87 | 26051181 | |
| 367 | Ubiquitination | HPERADAKDPASLPQ CHHHCCCCCCCCCCC | 65.87 | 29967540 | |
| 371 (in isoform 2) | Ubiquitination | - | 46.07 | - | |
| 371 | Ubiquitination | ADAKDPASLPQCLGP CCCCCCCCCCCHHCC | 46.07 | 29967540 | |
| 398 | Ubiquitination | CSDDCGMKLAANRIY CCCCCCCHHHHHHHH | 21.91 | 29967540 | |
| 402 (in isoform 2) | Ubiquitination | - | 25.85 | - | |
| 402 | Ubiquitination | CGMKLAANRIYEILP CCCHHHHHHHHHHHH | 25.85 | 29967540 | |
| 403 | Methylation | GMKLAANRIYEILPQ CCHHHHHHHHHHHHH | 28.30 | - | |
| 405 | Phosphorylation | KLAANRIYEILPQRI HHHHHHHHHHHHHHH | 8.15 | 28796482 | |
| 409 | Phosphorylation | NRIYEILPQRIQQWQ HHHHHHHHHHHHHHH | 27.37 | 27642862 | |
| 418 | Phosphorylation | RIQQWQQSPCIAEEH HHHHHHHCCCHHHHH | 13.46 | 28555341 | |
| 427 | Ubiquitination | CIAEEHGKKLLERIR CHHHHHHHHHHHHHH | 42.00 | 29967540 | |
| 427 | Acetylation | CIAEEHGKKLLERIR CHHHHHHHHHHHHHH | 42.00 | 26051181 | |
| 431 | Ubiquitination | EHGKKLLERIRREQQ HHHHHHHHHHHHHHH | 57.40 | 29967540 | |
| 431 (in isoform 2) | Ubiquitination | - | 57.40 | - | |
| 432 (in isoform 2) | Ubiquitination | - | 27.90 | - | |
| 462 | Ubiquitination | EAIILRAKQQAVRED HHHHHHHHHHHHHCC | 36.19 | - | |
| 466 (in isoform 2) | Ubiquitination | - | 6.31 | - | |
| 508 | Ubiquitination | HMERCYAKYESQTSF HHHHHHHHHCCCCCC | 24.07 | - | |
| 509 | Phosphorylation | MERCYAKYESQTSFG HHHHHHHHCCCCCCC | 16.79 | - | |
| 511 | Phosphorylation | RCYAKYESQTSFGSM HHHHHHCCCCCCCCC | 35.35 | - | |
| 512 (in isoform 2) | Ubiquitination | - | 29.26 | - | |
| 513 | Phosphorylation | YAKYESQTSFGSMYP HHHHCCCCCCCCCCC | 34.99 | 27080861 | |
| 514 | Phosphorylation | AKYESQTSFGSMYPT HHHCCCCCCCCCCCC | 21.70 | 27080861 | |
| 521 | Phosphorylation | SFGSMYPTRIEGATR CCCCCCCCCCCCCCE | 27.13 | - | |
| 539 | Ubiquitination | DVYNPQSKTYCKRLQ CCCCCCCHHHHHHHH | 37.96 | 29967540 | |
| 543 (in isoform 2) | Ubiquitination | - | 45.81 | - | |
| 543 | Ubiquitination | PQSKTYCKRLQVLCP CCCHHHHHHHHHHCC | 45.81 | 29967540 | |
| 557 | Ubiquitination | PEHSRDPKVPADEVC CCCCCCCCCCHHHCC | 66.20 | 29967540 | |
| 561 (in isoform 2) | Ubiquitination | - | 42.67 | - | |
| 561 | Ubiquitination | RDPKVPADEVCGCPL CCCCCCHHHCCCCCC | 42.67 | 29967540 | |
| 595 | Ubiquitination | NRHYCWEKLRRAEVD CCHHHHHHHHHCCCC | 23.85 | - | |
| 599 (in isoform 2) | Ubiquitination | - | 18.09 | - | |
| 611 | Ubiquitination | ERVRVWYKLDELFEQ HHHHHHHHHHHHHHH | 33.48 | - | |
| 615 (in isoform 2) | Ubiquitination | - | 5.97 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CXXC1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CXXC1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CXXC1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-63, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-224 AND THR-227, ANDMASS SPECTROMETRY. | |